Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at PLN 36.7B, ahead of BioNTech (PLN 34.2B) and Gilead Sciences (PLN 30.4B). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenPLN 36.7B
Median
PLN 1.7B
Combined market value
PLN 3.38T
Countries
5

Market values as of .

All countries
All sectors
Biotech
PLN
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CarePLN 36.7BPLN 970.5BPLN 1,794.15 2.52% down 34% up United States
2BioNTechBNTX · Health CarePLN 34.2BPLN 83.6BPLN 337.17 1.14% down 16% down Germany
3Gilead SciencesGILD · Health CarePLN 30.4BPLN 842.6BPLN 679.29 0.73% down 33% up United States
4argenxARGX · Health CarePLN 14BPLN 239.3BPLN 3,805.97 0.06% down 4% up Belgium
5BiogenBIIB · Health CarePLN 12.1BPLN 149.8BPLN 1,013.29 0.53% up 49% up United States
6ModernaMRNA · Health CarePLN 10.4BPLN 324.8BPLN 802.78 3.42% down 755% up United States
7ImmunovantIMVT · Health CarePLN 3.6BPLN 27.8BPLN 134.52 0.78% up 43% up United States
8QiagenQGEN · Health CarePLN 3.4BPLN 41.2BPLN 199.76 0.10% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CarePLN 2.9BPLN 66.7BPLN 659.04 1.18% down 20% up United States
10RepligenRGEN · Health CarePLN 2.3BPLN 44.6BPLN 696.94 6.92% up 5% up United States
11Krystal BiotechKRYS · Health CarePLN 2BPLN 37.6BPLN 1,267.35 5.62% up 46% up United States
12ExelixisEXEL · Health CarePLN 1.9BPLN 67.7BPLN 277.41 0.76% up 63% up United States
13Revolution MedicinesRVMD · Health CarePLN 1.5BPLN 139.6BPLN 645.37 1.30% down 131% up United States
14Kymera TherapeuticsKYMR · Health CarePLN 1.4BPLN 41.9BPLN 490.75 0.48% up 87% up United States
15CRISPR TherapeuticsCRSP · Health CarePLN 1.4BPLN 16.2BPLN 166.62 3.25% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CarePLN 1.3BPLN 23.3BPLN 191.20 5.52% up 14% up United States
17Bio-TechneTECH · Health CarePLN 1.1BPLN 46BPLN 292.62 0.24% up 26% up United States
18Kodiak SciencesKOD · Health CarePLN 843.5MPLN 25.4BPLN 388.74 0.08% down 396% up United States
19Twist BioscienceTWST · Health CarePLN 735.7MPLN 32.4BPLN 475.92 5.72% up 340% up United States
20VaxcytePCVX · Health CarePLN 699.2MPLN 37.4BPLN 235.99 1.15% down 22% up United States
21Halozyme TherapeuticsHALO · Health CarePLN 537.9MPLN 44.2BPLN 387.26 0.40% up 37% up United States
22ImmunityBioIBRX · Health CarePLN 355MPLN 28.7BPLN 26.99 7.27% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CarePLN 283.3MPLN 18.7BPLN 115.73 1.07% up 88% up United States
24CG OncologyCGON · Health CarePLN 130.6MPLN 28.8BPLN 322.46 1.63% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0193 PLN).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (PLN 36.7B), BioNTech (PLN 34.2B) and Gilead Sciences (PLN 30.4B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 18:41 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of PLN 3.38T as of 18 Nov 2026, 18:41 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.